Real World Experience of Crizotinib in 104 Patients With ALK Rearrangement Non-small-cell Lung Cancer in a Single Chinese Cancer Center

Purpose: Our study aimed to provide data on effectiveness, safety of crizotinib treatment, brain metastases, progression patterns, and sequential therapy beyond crizotinib treatment in patients with advanced ALK-positive NSCLC in China. Methods: We reviewed the medical records of crizotinib-treated...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Chang, Yu, Hui, Long, Qianqian, Chen, Haiquan, Li, Yuan, Zhao, Weixin, Zhao, Kuaile, Zhu, Zhengfei, Sun, Si, Fan, Min, Chang, Jianhua, Wang, Jialei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2019
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6817497/
https://www.ncbi.nlm.nih.gov/pubmed/31696059
http://dx.doi.org/10.3389/fonc.2019.01116

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6817497/
https://www.ncbi.nlm.nih.gov/pubmed/31696059
http://dx.doi.org/10.3389/fonc.2019.01116

Ejemplares similares